Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.

Home
/
Records
/
Fda Inspections
/
GlaxoSmithKline LLC

FDA Inspection

•GlaxoSmithKline LLC•February 20, 2026

FDA Inspection 1298596 - GlaxoSmithKline LLC - February 20, 2026

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Copilot

Record Details

This FDA Inspection record concerns GlaxoSmithKline LLC, with an inspection on February 20, 2026, covering drugs.

Company: GlaxoSmithKline LLC
Inspection Date: February 20, 2026
Product Type: Drugs

Open in Dashboard

ID · 1f15243a-fedd-4944-b624-120194c0b3fc

Global Key Solutions

Regulatory Data Transformed

Contact

New York Office:

370 Jay Street 7th Floor

Brooklyn, NY 11201

Scranton Office:

Scranton Enterprise Center, Suite 217

201 Lackawanna Avenue

Scranton, PA, 18503

🇺🇸+1 917-789-5099

🇪🇺+48 532-447-507

info@globalkeysolutions.net

Quick Links

KeyPedia™ Lite

Legal & Ethics

©2026, Global Key Solutions All rights reserved.

FDA Inspection 1298596 - GlaxoSmithKline LLC - February 20, 2026 | Global Key Solutions